The increasing complexity of cancer treatment necessitates a thorough understanding of diverse healthcare models. This article aims to analyze the advantages and weaknesses of transatlantic cancer care, evaluating the practices in both the United States and the European Union. Through a systemic lens, we will examine key factors, including healthca